The short version
Key takeaways
- Keep the regulatory scope explicit
- Understand what the medical review officer does
- Build the administrative handoff around verified status
Purpose and scope
A workplace drug-testing result depends on the process that produced and reviewed it. An informal screen, a laboratory-confirmed finding, and a result verified by a medical review officer are not interchangeable labels.
Keep the regulatory scope explicit
This article concerns the US Department of Transportation testing framework. It is not a universal rulebook for private employers or non-DOT programs. The applicable DOT agency requirements and current 49 CFR Part 40 procedures need to be assessed for the actual role and employer.
Before arranging a test, have the responsible program professional identify the correct program, reason for testing, collection process, and service providers. Do not substitute an over-the-counter test because it appears to measure similar substances.
Understand what the medical review officer does
DOT describes an MRO as a licensed physician who reviews laboratory drug-testing results and evaluates relevant medical explanations. The role includes protecting the integrity and confidentiality of the process. A laboratory finding can therefore be an input to a defined review process rather than a manager's invitation to make a medical judgment.
Employees should use the designated confidential route for medical information requested during that process. Supervisors should not solicit medicine lists in a shared team chat or attempt to decide whether a prescription explains a laboratory finding.
Build the administrative handoff around verified status
Document who receives authorized reports, who communicates with the testing service, and how outstanding steps are tracked. Distinguish collected, pending laboratory work, pending review, and the final status supplied through the applicable process.
Have qualified advisers address employment actions, deadlines, and other legal obligations. A short educational guide cannot establish the correct action for an individual case, and this article does not provide drug-detection windows or methods for evading testing.
The business value of a clear process is fewer improvised decisions and a more reliable record of who is responsible. Use current DOT materials and qualified program professionals to implement the requirements, rather than treating any test labeled drug screen as an equivalent purchase.
References and examples
Primary sources and product examples used to ground this guide. Product links are editorial references, not endorsements.